Tiger Medicine (300347.SZ): Plans to invest 200 million yuan to participate in Shanghai Sansheng Medicine Private Equity Investment Fund.

Wisdom Financial APP News, Tager Pharmaceuticals (300347.SZ) announced that the company plans to participate in the Shanghai Sansheng Medical Private Equity Investment Fund Partnership Enterprise (Limited Partnership) through Hangzhou Tager Equity Investment Partnership Enterprise (Limited Partnership) (referred to as the "investment entity"). The first phase of the partnership enterprise plans to subscribe a total of 950 million yuan, and the investment entity will subscribe 200 million yuan as a limited partner (LP) of the partnership enterprise with its own funds.